Harri Hemila and Elizabeth Chalker at the University of Helsinki published the definitive Cochrane systematic review on vitamin C and the common cold in 2013. This review examined 29 placebo-controlled trials involving 11,306 participants who took at least 200 mg of vitamin C daily.

The central finding was clear: regular daily vitamin C supplementation failed to reduce how often people caught colds. For the general population, taking vitamin C every day simply did not prevent colds. There was a modest reduction in how long colds lasted - about 8% shorter in adults - which translates to roughly one fewer day of symptoms for an adult cold that normally lasts about 12 days.

The reviewers also looked at 7 trials where people started taking vitamin C only after cold symptoms began, and found no benefit whatsoever from this therapeutic use. This is critical because the most common consumer behavior is to reach for vitamin C when they already feel sick, which the evidence says does not work.

Carmen Audera and colleagues at the Australian National University conducted a double-blind, randomized trial published in the Medical Journal of Australia in 2001. They recruited 400 healthy volunteers and assigned them to four groups: a near-placebo dose of 0.03 grams per day, or 1 gram, 3 grams, or 3 grams with added bioflavonoids. Participants took the supplements at the onset of cold symptoms and continued for two days.

The results were unambiguous. Doses of vitamin C well above the recommended daily intake, taken shortly after a cold began, did not reduce how long the cold lasted or how severe the symptoms were. Even the 3-gram daily dose - roughly 33 times the recommended daily amount - performed no better than the tiny 0.03-gram control dose.

This trial directly tested the popular advice to "load up on vitamin C when you feel a cold coming on," and showed that this approach simply does not work. The 400-person sample size gave it reasonable statistical power to detect a meaningful difference if one existed.

The NIH Office of Dietary Supplements, which reviews the totality of scientific evidence on nutritional supplements, maintains a health professional fact sheet on vitamin C that directly addresses cold prevention and treatment. Their position, based on the accumulated research, is that vitamin C supplements do not reduce the risk of getting the common cold for most people.

The NIH notes that regular supplementation of 200 mg per day or more did not affect the incidence of colds in the general population. For people who do take vitamin C daily before getting sick, cold duration was shortened modestly. But the NIH emphasizes that taking vitamin C supplements after cold symptoms have already started does not appear to be helpful.

The NIH also sets the tolerable upper intake level for vitamin C at 2,000 mg per day for adults, noting that exceeding this amount can cause diarrhea, nausea, and abdominal cramps, and that the body cannot absorb or use megadoses effectively because excess vitamin C is simply excreted in urine.

Mayo Clinic, one of the most respected medical institutions in the United States, has directly addressed the vitamin C and cold question through its physicians and published guidance. Dr. Jesse Bracamonte, a Mayo Clinic family physician, explained that taking extra vitamin C to prevent colds has not proven to be true. The evidence shows that if a cold normally lasts about a week, taking vitamin C might reduce that by roughly 13 hours.

Mayo Clinic''s cold remedies guide lists vitamin C in the category of remedies with conflicting evidence rather than proven effectiveness. They note that while vitamin C may provide some marginal benefit for people who take it regularly before getting sick, the effect is so small as to be barely noticeable in everyday life.

This institutional position matters because Mayo Clinic bases its guidance on systematic evaluation of clinical evidence, and their conclusion aligns with the Cochrane review and NIH position: vitamin C does not prevent colds, and whatever shortening of symptoms it may provide is clinically trivial.

Laura Thomas and colleagues at the Karolinska Institutet in Sweden published a prospective cohort study in JAMA Internal Medicine in 2013 that tracked 23,355 men over 11 years. During that period, 436 men developed kidney stones. The researchers found that men who regularly took vitamin C supplements - which in Sweden typically contain 1,000 mg per tablet - had roughly double the risk of developing kidney stones compared to men who did not take vitamin C supplements.

The mechanism behind this risk is well understood. The human body converts a portion of ingested vitamin C into oxalate, a waste product that is excreted through the kidneys. A single 1-gram dose of vitamin C can increase urinary oxalate levels by up to 60%. Oxalate combines with calcium in the urine to form calcium oxalate crystals, which are the most common type of kidney stone.

Men who took standard multivitamins (which contain much lower doses of vitamin C, typically 60-90 mg) did not have an increased kidney stone risk. This finding specifically implicates the high doses used in dedicated vitamin C supplements.

The U.S. Institute of Medicine (now the National Academy of Medicine) established a tolerable upper intake level of 2,000 mg per day for vitamin C in adults, specifically based on gastrointestinal side effects. Above this threshold, vitamin C draws excess water into the intestines and increases stomach acidity, reliably producing diarrhea, nausea, and abdominal cramping.

This is directly relevant because many popular protocols and products recommend "megadose" vitamin C at 3,000 to 10,000 mg per day at the onset of cold symptoms. At these doses, gastrointestinal distress is essentially guaranteed. The human body can only absorb about 200-500 mg of vitamin C at a time; any excess is either excreted in urine or causes osmotic diarrhea.

Taking 10 grams of vitamin C daily, as Linus Pauling recommended, means the vast majority is wasted and the person suffers predictable digestive side effects for no proven cold benefit. Vitamin C from food does not cause these problems because dietary sources deliver much lower, better-absorbed doses.

Linus Pauling, a two-time Nobel laureate (chemistry and peace), published "Vitamin C and the Common Cold" in 1970, claiming that 1,000 mg or more of vitamin C daily could dramatically reduce cold incidence. Despite his enormous scientific reputation, his claims about vitamin C were based on a small number of early trials, and he extrapolated far beyond what the data supported. Over subsequent years, he escalated his recommended dose to 6,000-18,000 mg per day.

The Journal of the American Medical Association reviewed Pauling''s book and was blunt in its assessment, stating the book contained not the guarded statements of a scientist seeking truths, but the sentences of an advertiser with something to sell. At least 16 well-designed, double-blind studies conducted after Pauling''s book was published showed that vitamin C supplementation does not prevent colds and at best may slightly reduce symptom duration.

Pauling''s advocacy nevertheless created a massive supplement industry. His case is often cited in the history of science as an example of how a brilliant scientist can become irrationally attached to an idea outside their area of expertise.

Terence Anderson, Donald Reid, and George Beaton at the University of Toronto conducted one of the first large-scale, properly controlled trials of vitamin C and the common cold, published in the Canadian Medical Association Journal in 1972. They recruited 818 volunteers and randomized them to receive either 1 gram of vitamin C per day or a placebo, tracking them through the cold season. The trial recorded 1,170 episodes of illness.

The key finding was that while the vitamin C group experienced slightly fewer colds and sick days than the placebo group, the differences were smaller than Pauling had claimed and were statistically not significant for cold prevention. In plain terms, the small difference they observed could easily have occurred by chance.

Anderson went on to conduct additional trials in the 1970s, and his overall body of work consistently showed that vitamin C''s effects on cold prevention were either absent or too small to matter practically. His research was instrumental in shifting the scientific consensus away from Pauling''s claims.